Currently, there are 46.36M common shares owned by the public and among those 42.23M shares have been available to trade.
The company’s stock has a 5-day price change of -2.99% and -82.27% over the past three months. XXII shares are trading -96.73% year to date (YTD), with the 12-month market performance down to -97.82% lower. It has a 12-month low price of $0.08 and touched a high of $5.28 over the same period. XXII has an average intraday trading volume of 7.66 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.65%, -41.22%, and -90.66% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of 22nd Century Group Inc (NASDAQ: XXII) shares accounts for 9.80% of the company’s 46.36M shares outstanding.
It has a market capitalization of $4.52M and a beta (3y monthly) value of 1.51. The earnings-per-share (ttm) stands at -$22.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.30% over the week and 12.31% over the month.
Looking at the support for the XXII, a number of firms have released research notes about the stock. Alliance Global Partners stated their Buy rating for the stock in a research note on July 21, 2022, with the firm’s price target at $5. Craig Hallum coverage for the 22nd Century Group Inc (XXII) stock in a research note released on June 15, 2022 offered a Buy rating with a price target of $5. ROTH Capital was of a view on March 08, 2022 that the stock is Buy, while Cowen gave the stock Outperform rating on July 23, 2021, issuing a price target of $5. Chardan Capital Markets on their part issued Buy rating on October 16, 2017.
